PROM1 and colonic neoplasm: The CD133+ subpopulation of colon cancer cells was recently demonstrated to be highly enriched in tumour-initiating Co-CSCs, whereas in contrast, CD133− tumour cells did not have tumour-initiating capabilities (O'Brien et al, 2007; Ricci-Vitiani et al, 2007).